TGF-β-induced epithelial to mesenchymal transition
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akhurst R . TGF-β signaling in epithelial-mesenchymal transition and invasion and metastasis. In: Derynck R, Miyazono K, eds. The TGF-beta family. Cold Spring Harbor Laboratory Press: New York 2007:939–964.
Tsukita S, Furuse M, Itoh M . Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2:285–293.
Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D . Polarity complex proteins. Biochim Biophys Acta 2008; 1778:614–630.
Martin-Belmonte F, Mostov K . Regulation of cell polarity during epithelial morphogenesis. Curr Opin Cell Biol 2008; 20:227–234.
Niessen CM, Gottardi CJ . Molecular components of the adherens junction. Biochim Biophys Acta 2008; 1778:562–571.
Wheelock MJ, Johnson KR . Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003; 19:207–235.
Llorens A, Rodrigo I, Lopez-Barcons L, et al. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab Invest 1998; 78:1131–1142.
Navarro P, Lozano E, Cano A . Expression of E-or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. J Cell Sci 1993; 105:923–934.
Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927–939.
Ansieau S, Bastid J, Doreau A, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 2008; 14:79–89.
De Craene B, Gilbert B, Stove C, et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005; 65:6237–6244.
Ohkubo T, Ozawa M . The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 2004; 117:1675–1685.
Garrod D, Chidgey M . Desmosome structure, composition and function. Biochim Biophys Acta 2008; 1778:572–587.
Yin T, Green KJ . Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 2004; 15:665–677.
Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2:76–83.
Savagner P, Yamada KM, Thiery JP . The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137:1403–1419.
Miettinen PJ, Ebner R, Lopez AR, Derynck R . TGF-β-induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994; 127:2021–2036.
Imamichi Y, Menke A . Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition. Cells Tissues Organs 2007; 185:180–190.
Zhao Y, Min C, Vora S, et al. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of FAK and p130CAS in breast cancer cells. J Biol Chem 2008 Nov 21. doi: 10.1074/jbc.M802612200 .
Frame MC, Inman GJ . NCAM is at the heart of reciprocal regulation of E-cadherinand integrin-mediated adhesions via signaling modulation. Dev Cell 2008; 15:494–496.
Shirakihara T, Saitoh M, Miyazono K . Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol Biol Cell 2007; 18:3533–3544.
Deckers M, van Dinther M, Buijs J, et al. The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 2006; 66:2202–2209.
Cavallaro U, Christofori G . Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4:118–132.
Grunert S, Jechlinger M, Beug H . Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4:657–665.
Moustakas A, Heldin CH . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98:1512–1520.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7:415–428.
Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P . TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 1999; 112:4557–4568.
Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A . TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16:1987–2002.
Shook D, Keller R . Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003; 120:1351–1383.
Kishigami S, Mishina Y . BMP signaling and early embryonic patterning. Cytokine Growth Factor Rev 2005; 16:265–278.
Lee JM, Dedhar S, Kalluri R, Thompson EW . The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172:973–981.
Nakajima Y, Yamagishi T, Hokari S, Nakamura H . Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-β and bone morphogenetic protein (BMP). Anat Rec 2000; 258:119–127.
Mercado-Pimentel ME, Runyan RB . Multiple transforming growth factor-β isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007; 185:146–156.
Azhar M, Schultz Jel J, Grupp I, et al. Transforming growth factor β in cardiovascular development and function. Cytokine Growth Factor Rev 2003; 14:391–407.
Pelton RW, Hogan BL, Miller DA, Moses HL . Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation. Dev Biol 1990; 141:456–460.
Nawshad A, LaGamba D, Hay ED . Transforming growth factor β (TGFβ) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 2004; 49:675–689.
Klattig J, Englert C . The Müllerian duct: recent insights into its development and regression. Sex Dev 2007; 1:271–278.
Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213:374–383.
Cui W, Fowlis DJ, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86:531–542.
Derynck R, Akhurst RJ, Balmain A . TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001; 29:117–129.
Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341–350.
Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC . TGF-β signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284:F243–F252.
Willis BC, Borok Z . TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293:L525–L534.
Gressner AM, Weiskirchen R, Breitkopf K, Dooley S . Roles of TGF-β in hepatic fibrosis. Front Biosci 2002; 7:d793–d807.
Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13:952–961.
Feng XH, Derynck R . Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 2005; 21:659–693.
Portella G, Cumming SA, Liddell J, et al. Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 1998; 9:393–404.
Oft M, Heider KH, Beug H . TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8:1243–1252.
Han G, Lu SL, Li AG, et al. Distinct mechanisms of TGF-β1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005; 115:1714–1723.
Lamouille S, Derynck R . Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 2007; 178:437–451.
Eger A, Stockinger A, Park J, et al. β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 2004; 23:2672–2680.
Mercado-Pimentel ME, Hubbard AD, Runyan RB . Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 2007; 304:420–432.
Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A . Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003; 112:1486–1494.
Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1:260–266.
Hoot KE, Lighthall J, Han G, et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 2008; 118:2722–2732.
Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 2006; 26:654–667.
Oft M, Akhurst RJ, Balmain A . Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 2002; 4:487–494.
Takano S, Kanai F, Jazag A, et al. Smad4 is essential for down-regulation of E-cadherin induced by TGF-β in pancreatic cancer cell line PANC-1. J Biochem 2007; 141:345–351.
Kaimori A, Potter J, Kaimori JY, et al. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 2007; 282:22089–22101.
Bardeesy N, Cheng KH, Berger JH, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006; 20:3130–3146.
Desgrosellier JS, Mundell NA, McDonnell MA, Moses HL, Barnett JV . Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 2005; 280:201–210.
Armstrong EJ, Bischoff J . Heart valve development: endothelial cell signaling and differentiation. Circ Res 2004; 95:459–470.
Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest 2004; 84:1259–1270.
Xu GP, Li QQ, Cao XX, et al. The fffect of TGF-β1 and SMAD7 gene transfer on the phenotypic changes of rat alveolar epithelial cells. Cell Mol Biol Lett 2007; 12:457–472.
Dooley S, Hamzavi J, Ciuclan L, et al. Hepatocyte-specific Smad7 expression attenuates TGF-β-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008; 135:642–659.
Zavadil J, Böttinger EP . TGF-β and epithelial-to-mesenchymal transitions. Oncogene 2005; 24:5764–5774.
Nieto MA . The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3:155–166.
Barrallo-Gimeno A, Nieto MA . The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132:3151–3161.
Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2:84–89.
Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT . Human Slug is a repressor that localizes to sites of active transcription. Mol Cell Biol 2000; 20:5087–5095.
Jamora C, Lee P, Kocieniewski P, et al. A signaling pathway involving TGF-β2 and snail in hair follicle morphogenesis. PLoS Biol 2005; 3:e11.
Martinez-Alvarez C, Blanco MJ, Perez R, et al. Snail family members and cell survival in physiological and pathological cleft palates. Dev Biol 2004; 265:207–218.
Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348:403–413.
Peinado H, Quintanilla M, Cano A . Transforming growth factor β1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278:21113–21123.
Romano LA, Runyan RB . Slug is an essential target of TGFβ2 signaling in the developing chicken heart. Dev Biol 2000; 223:91–102.
Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J . Snail is required for transforming growth factor-β-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 2007; 353:337–343.
Morita T, Mayanagi T, Sobue K . Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol 2007; 179:1027–1042.
Grotegut S, von Schweinitz D, Christofori G, Lehembre F . Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25:3534–3545.
Olmeda D, Jorda M, Peinado H, Fabra A, Cano A . Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 2007; 26:1862–1874.
Bolos V, Peinado H, Perez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003; 116:499–511.
Hajra KM, Chen DY, Fearon ER . The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62:1613–1618.
Carver EA, Jiang R, Lan Y, Oram KF, Gridley T . The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001; 21:8184–8188.
Nieto MA, Sargent MG, Wilkinson DG, Cooke J . Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994; 264:835–839.
Ikenouchi J, Matsuda M, Furuse M, Tsukita S . Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116:1959–1967.
Kajita M, McClinic KN, Wade PA . Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004; 24:7559–7566.
Wang Z, Wade P, Mandell KJ, et al. Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor slug. Oncogene 2007; 26:1222–1230.
Kurrey NK, K A, Bapat SA . Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005; 97:155–165.
Whiteman EL, Liu CJ, Fearon ER, Margolis B . The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene 2008; 27:3875–3879.
Guaita S, Puig I, Franci C, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002; 277:39209–39216.
Moreno-Bueno G, Cubillo E, Sarrio D, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006; 66:9543–9556.
Boutet A, De Frutos CA, Maxwell PH, et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006; 25:5603–5613.
Boutet A, Esteban MA, Maxwell PH, Nieto MA . Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis? Cell Cycle 2007; 6:638–642.
Cicchini C, Filippini D, Coen S, et al. Snail controls differentiation of hepatocytes by repressing HNF4α expression. J Cell Physiol 2006; 209:230–238.
Hattrup CL, Gendler SJ . Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008; 70:431–457.
Taki M, Verschueren K, Yokoyama K, Nagayama M, Kamata N . Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int J Oncol 2006; 28:487–496.
Jorda M, Olmeda D, Vinyals A, et al. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci 2005; 118:3371–3385.
Postigo AA, Depp JL, Taylor JJ, Kroll KL . Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 2003; 22:2453–2462.
Postigo AA . Opposing functions of ZEB proteins in the regulation of the TGFβ/BMP signaling pathway. EMBO J 2003; 22:2443–2452.
Nishimura G, Manabe I, Tsushima K, et al. DeltaEF1 mediates TGF-β signaling in vascular smooth muscle cell differentiation. Dev Cell 2006; 11:93–104.
Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10:593–601.
Park SM, Gaur AB, Lengyel E, Peter ME . The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22:894–907.
Korpal M, Lee ES, Hu G, Kang Y . The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283:14910–14914.
Long J, Zuo D, Park M . Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem 2005; 280:35477–35489.
Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001; 7:1267–1278.
Grooteclaes ML, Frisch SM . Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 2000; 19:3823–3828.
Eger A, Aigner K, Sonderegger S, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24:2375–2385.
Vandewalle C, Comijn J, De Craene B, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005; 33:6566–6578.
Bindels S, Mestdagt M, Vandewalle C, et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006; 25:4975–4985.
Spaderna S, Schmalhofer O, Wahlbuhl M, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008; 68:537–544.
Aigner K, Dampier B, Descovich L, et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26:6979–6988.
Massari ME, Murre C . Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000; 20:429–440.
Perez-Moreno MA, Locascio A, Rodrigo I, et al. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 2001; 276:27424–27431.
Kondo M, Cubillo E, Tobiume K, et al. A role for Id in the regulation of TGF-β-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ 2004; 11:1092–1101.
Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A . Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24:4241–4254.
Kang Y, Chen CR, Massagué J . A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003; 11:915–926.
Chen ZF, Behringer RR . Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995; 9:686–699.
el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nature Genetics 1997; 15:42–46.
Howard TD, Paznekas WA, Green ED, et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nature Genetics 1997; 15:36–41.
Yang J, Mani SA, Weinberg RA . Exploring a new twist on tumor metastasis. Cancer Res 2006; 66:4549–4552.
Thuault S, Valcourt U, Petersen M, et al. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 2006; 174:175–183.
Derynck R, Zhang YE . Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003; 425:577–584.
Kretzschmar M, Doody J, Timokhina I, Massagué J . A mechanism of repression of TGFβ/ Smad signaling by oncogenic Ras. Genes Dev 1999; 13:804–816.
Funaba M, Zimmerman CM, Mathews LS . Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002; 277:41361–41368.
Lehmann K, Janda E, Pierreux CE, et al. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 2000; 14:2610–2622.
Davies M, Robinson M, Smith E, et al. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005; 95:918–931.
Lee MK, Pardoux C, Hall MC, et al. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 2007; 26:3957–3967.
Galliher AJ, Schiemann WP . Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 2007; 67:3752–3758.
Grande M, Franzén A, Karlsson JO, et al. Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002; 115:4227–4236.
Janda E, Lehmann K, Killisch I, et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002; 156:299–313.
Uttamsingh S, Bao X, Nguyen KT, et al. Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008; 27:2626–2634.
Xie L, Law BK, Chytil AM, et al. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004; 6:603–610.
Schmidt CR, Gi YJ, Patel TA, et al. E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells. Surgery 2005; 138:306–312.
Marchetti A, Colletti M, Cozzolino AM, et al. ERK5/MAPK is activated by TGFβ in hepatocytes and required for the GSK-3β-mediated Snail protein stabilization. Cell Signal 2008; 20:2113–2118.
Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL . p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 2002; 115:3193–3206.
Yu L, Hébert MC, Zhang YE . TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 2002; 21:3749–3759.
Sano Y, Harada J, Tashiro S, et al. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-signaling. J Biol Chem 1999; 274:8949–8957.
Santibanez JF . JNK mediates TGF-β1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett 2006; 580:5385–5391.
Alcorn JF, Guala AS, van der Velden J, et al. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1. J Cell Sci 2008; 121:1036–1045.
Liu Q, Mao H, Nie J, et al. Transforming growth factor β1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 2008; 28 Suppl 3:S88–S95.
Han S, Ritzenthaler JD, Sitaraman SV, Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 2006; 281:29614–29624.
Wang W, Zhou G, Hu M, Yao Z, Tan TH . Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, Stress activated c-Jun N-terminal Kinase (JNK) pathway by transforming growth factor-β (TGF-β)-activated Kinase (TAK1), a kinase mediator of TGF-β signal transduction. J Biol Chem 1997; 272:22771–22775.
Delaney JR, Mlodzik M . TGF-β activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 2006; 5:2852–2855.
Yamashita M, Fatyol K, Jin C, et al. TRAF6 mediates Smad-indepent activation of JNK and p38 by TGF-β. Mol Cell 2008; 31:918–924.
Sorrentino A, Thakur N, Grimsby S, et al. The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008; 10:1199–1207.
Tavares AL, Mercado-Pimentel ME, Runyan RB, Kitten GT . TGF-β-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 2006; 235:1589–1598.
Cho HJ, Yoo J . Rho activation is required for transforming growth factor-β-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 2007; 31:1225–1230.
Vardouli L, Moustakas A, Stournaras C . LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-β. J Biol Chem 2005; 280:11448–11457.
Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27–36.
Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity. Science 2005; 307:1603–1609.
Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL . Phosphatidylinositol 3-kinase function is required for transforming growth factor-β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275:36803–36810.
Lee YI, Kwon YJ, Joo CK . Integrin-linked kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun 2004; 316:997–1001.
Rodriguez-Barbero A, Dorado F, Velasco S, et al. TGF-β1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int 2006; 70:901–909.
Lien SC, Usami S, Chien S, Chiu JJ . Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-β1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal 2006; 18:1270–1278.
Lin CC, Chiang LL, Lin CH, et al. Transforming growth factor-β1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-κB pathways in human lung epithelial cells. Eur J Pharmacol 2007; 560:101–109.
Yeh YY, Chiao CC, Kuo WY, et al. TGF-β1 increases motility and αvβ3 integrin up-regulation via PI3K, Akt and NF-κB-dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 2008; 75:1292–1301.
Yi JY, Shin I, Arteaga CL . Type I transforming growth factor β receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem 2005; 280:10870–10876.
Sarbassov DD, Ali SM, Sabatini DM . Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005; 17:596–603.
Kattla JJ, Carew RM, Heljic M, Godson C, Brazil DP . Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 2008; 295:F215–225.
Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS . p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 2008; 68:6524–6532.
Nelson WJ, Nusse R . Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004; 303:1483–1487.
Liebner S, Cattelino A, Gallini R, et al. β-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol 2004; 166:359–367.
Nawshad A, Medici D, Liu CC, Hay ED . TGFβ3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 2007; 120:1646–1653.
Zavadil J, Cermak L, Soto-Nieves N, Böttinger EP . Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23:1155–1165.
Grego-Bessa J, Diez J, Timmerman L, de la Pompa JL . Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 2004; 3:718–721.